A Herbalist’s Guide to Using CBD Oil

CBD sits in a strange place.

On one side, it’s genuinely one of the most interesting phytochemicals in modern herbal medicine. It’s a non-intoxicating cannabinoid with real pharmacology and a ton of high-quality research backing its many applications.

On the other side, it’s sold like snake oil.

If you spend any time talking to someone passionate about CBD oil or reading the blog posts of CBD oil companies, you’ll come to the conclusion that this stuff can cure anything.

It’s recommended for anxiety, sleep, pain, inflammation, cancer, skin problems, autoimmune disease, Alzheimer’s, addiction, pets, workouts, skincare… Whatever the problem is, someone is selling CBD for it.

Some of these claims are reasonable. A few are genuinely well supported. Most are still early. A couple are flat-out wrong.

That’s the point of this guide — not to hype CBD, and not to dismiss it. I use CBD and find it to be a very useful herbal extract for certain situations (when matched to the right problem, used at a realistic dose, and sourced from a company that can prove what’s inside the bottle).

The problem is that most people are buying CBD in the dark.

This guide is meant to fix that.

We’ll look at what CBD actually is, how hemp is different from high-THC cannabis, what the evidence really supports, how to compare isolates with full-spectrum extracts, how to think about dose, and where CBD can get risky — especially with prescription medications.

CBD Evidence Map: What’s Proven, Promising, Shaky, or Wrong

CBD has been studied for a long list of conditions, but the evidence is not evenly distributed.

Some claims have clinical evidence. Some are supported mostly by animal or cell-culture research (useful, but far from definitive). Some are plausible but not proven. Others are repeated online despite being weak, misleading, or flat-out wrong.

The chart below is an editorial evidence score — not a guarantee that CBD will work, and not a measure of effect size. It’s a way of ranking how strong the current support is for each major claim.

Click a claim to jump directly to its section.

CBD, Hemp & The Cannabis Plant

CBD comes from cannabis — but that word carries a lot of baggage.

Botanically, cannabis is usually discussed as Cannabis sativa L., with familiar market categories like sativa, indica, hybrid, and ruderalis layered on top. Those categories can describe growth habit, breeding history, leaf shape, aroma, or market positioning, but they don’t reliably tell you what the plant will do in the body.

The more useful concept is the chemotype.

A cannabis chemotype is defined by chemistry: how much THC, CBD, CBG, CBC, CBN, terpenes, and other compounds the plant produces. Two plants can both be sold as “indica” and have completely different effects because their chemical profiles are different.

Hemp is another term that causes confusion.

Hemp is not a separate species of cannabis. In legal terms, hemp usually means Cannabis sativa L. that produces no more than 0.3% total THC on a dry-weight basis. In the United States, hemp testing also accounts for THCA conversion into THC.

So the important distinction is not “hemp vs cannabis” — it’s “high-THC cannabis, low-THC hemp, CBD-dominant chemotypes, balanced THC:CBD chemotypes, and the specific cannabinoid/terpene profile shown on the lab report.”

This is why the lab report matters so much. A CBD product is not automatically good because it came from hemp, and a full-spectrum extract is not automatically better because it contains more of the plant.

What matters is the chemistry.

Why “Indica vs Sativa” Is the Wrong Question

The old dispensary shorthand says indica is relaxing and sativa is stimulating.

It’s easy to remember. It’s also not very reliable.

Modern cannabis genetics are messy, and most commercial plants are hybrids. The sativa–indica scale does not reliably capture the chemical diversity between cannabis products. Two “indicas” can feel completely different. Two “sativas” can produce opposite effects.

That’s because the effect of cannabis is shaped by chemistry, not folklore.

The more relevant questions are:

• How much CBD is present?
• How much THC is present?
• Is the product isolate, broad-spectrum, or full-spectrum?
• What other cannabinoids are present?
• What terpenes are present?
• Does the company publish a current certificate of analysis?
• Does the chemistry match the effect the product is claiming?

This matters for CBD products too.

A full-spectrum CBD oil is not just “CBD.” It may contain trace THC, CBG, CBC, CBN, acidic cannabinoids, terpenes, flavonoids, and other resin compounds. Those supporting compounds can change how the extract feels and performs.

That doesn’t mean every full-spectrum product is automatically superior. It means the chemistry needs to be visible.

If a company is asking you to trust the plant, it should show you the profile.

How CBD Works In The Body

CBD is often described as “non-psychoactive,” but that word is a little misleading.

CBD is not intoxicating in the way THC is. It does not reliably produce a cannabis high. But it does affect the nervous system, inflammation pathways, liver enzymes, neurotransmitter systems, and the endocannabinoid system.

CBD interacts with several systems at once. That’s one reason it has attracted so much research — and also one reason CBD marketing gets out of hand so quickly.

The main systems include:

1. The Endocannabinoid System

The endocannabinoid system helps regulate mood, pain signaling, appetite, inflammation, immune tone, sleep, stress response, and homeostasis.

THC works mainly by directly activating cannabinoid receptors, especially CB1 receptors in the nervous system. CBD behaves differently. It does not strongly activate CB1 in the same direct way, which is one reason it does not feel like THC.

CBD appears to influence the endocannabinoid system more indirectly.

2. Serotonin Signaling

CBD may interact with serotonin receptors, especially 5-HT1A. This is one proposed mechanism behind its anxiety-related effects.

This does not mean CBD works like an SSRI or a benzodiazepine. It means some of its effects may overlap with stress, fear, and mood-regulation pathways.

3. TRP Channels & Pain Signaling

CBD may interact with TRP channels, including TRPV1, which are involved in pain, heat, irritation, and inflammatory signaling.

This is part of why CBD is often discussed for pain and topical use, though the clinical evidence for CBD alone remains much weaker than the marketing suggests.

4. Inflammation & Immune Signaling

CBD has shown anti-inflammatory and immunomodulating activity in preclinical models. This is one of the reasons it gets discussed for autoimmune disease, inflammatory pain, skin conditions, and neuroinflammation.

But this is where the distinction between mechanism and outcome matters.

A compound can reduce inflammatory markers in a lab model without meaningfully treating an inflammatory disease in a person. This is one of the biggest problems in CBD marketing.

Mechanism is not proof.

5. Liver Enzymes & Drug Metabolism

CBD affects enzymes that help break down many medications, especially CYP3A4 and CYP2C19, with possible effects on CYP2C9 and other pathways.

This is one of the most clinically important things about CBD.

The same property that makes it pharmacologically interesting also makes it capable of interacting with prescription medications.

More on this in the safety section.

What Is CBD Actually Good For?

CBD is one of the most heavily discussed compounds in herbal medicine. But “discussed” is not the same as “proven.”

This section works through each major claim in detail. The chart above ranks them by evidence strength; here’s the reasoning behind each score.

Each section includes:

• Evidence score
• Evidence tag
• What the research suggests
• What CBD should not be expected to do
• What still needs more research

Severe Seizure Disorders

This is the one area where CBD has regulatory-grade evidence.

A purified pharmaceutical form of CBD is approved for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex in patients one year and older.

This is not a vague wellness claim. This is CBD used as a real medicine, at high doses, under medical supervision, with attention to liver enzymes, drug interactions, and seizure-medication combinations.

But this use also gets misrepresented.

This is also, incidentally, what most pharmaceutical-grade CBD is made for — purified, high-dose CBD prescribed and monitored for these specific syndromes. And the dose gap between that and a wellness product is enormous. Prescription CBD (Epidiolex) is dosed by body weight, at roughly 10–20 mg/kg per day. For a 70 kg adult, that works out to somewhere around 700–1,400 mg of CBD every day, taken with regular liver-function monitoring.

Now compare that to a typical over-the-counter CBD oil. A “1000 mg” bottle in 30 mL works out to about 33 mg of CBD per mL — so a normal 1 mL serving gives you around 33 mg. To get anywhere near the low end of the epilepsy dose, you’d have to take roughly 20+ mL a day: most of a bottle, every single day. That’s not how these products are designed to be used, and it isn’t realistic on cost alone.

So when you see a wellness brand implying their gummies or oil can treat seizures, understand that the approved seizure evidence lives at a completely different dose, in a completely different product, under medical supervision. The epilepsy trials used pharmaceutical interventions — not casual “a few drops before bed” protocols.

Anxiety

Anxiety is where CBD looks most promising outside of seizure disorders — and probably the most relevant use for over-the-counter CBD oil customers.

Small human trials suggest CBD may reduce anxiety in specific situations, especially acute stress models like public speaking. Other studies and reviews suggest CBD may have potential for more substantial anxiety disorders.

This is also where many people report the most noticeable benefit from CBD.

The proposed mechanisms make sense. CBD may influence serotonin signaling, endocannabinoid tone, fear processing, stress response, and inflammatory pathways that interact with mood.

The human signal is strong and fairly consistent — what’s still messy is the protocol.

The studies use different doses, different populations, different product types, and different outcome measures. Some use single large doses. Others use daily dosing. Some involve healthy volunteers. Others involve diagnosed anxiety disorders.

So while the direction of the evidence is clear, it’s hard to distil into one universal dose or product.

But I can say that I have personally seen high-dose CBD oil used in highly anxious states with great effect. It’s one of the first things I reach for in a highly anxious individual.

Inflammation

CBD is often described as anti-inflammatory — and this is one of the better-supported parts of its pharmacology.

The mistake is treating “inflammation” like it’s all the same thing. It isn’t.

Inflammation can mean acute swelling after an injury, chronic immune activation, autoimmune tissue attack, irritated skin, inflamed joints, gut inflammation, neuroinflammation, oxidative stress, mast-cell activation, cytokine signaling, or low-grade metabolic inflammation. These are all related — but they are all distinct processes.

CBD does not “turn off inflammation” in a general sense. That would not even be desirable. Inflammation is part of healing, immune defense, tissue cleanup, and infection control. Turning it off would be catastrophic for the body.

What CBD appears to do is much more specific — it modulates several inflammatory signaling pathways. This is going to get a bit technical, but it’s important to make these distinctions because they show just how complicated “inflammation” actually is.

CBD has been studied for effects on:

• NF-κB — one of the major transcription pathways that switches on inflammatory genes.
• TLR4 signaling — part of the innate immune alarm system involved in inflammatory activation.
• Pro-inflammatory cytokines — including mediators such as IL-6, IL-8, TNF-α, and IL-1β.
• MMP-3 — a tissue-remodeling enzyme relevant in inflammatory joint disease.
• NLRP3 inflammasome activity — a cellular inflammatory complex involved in IL-1β signaling and sterile inflammation.
• PPARγ — a nuclear receptor involved in inflammation, metabolism, and immune regulation.
• TRPV1 and related TRP channels — involved in pain, heat, irritation, and neurogenic inflammation.
• Oxidative stress — one of the drivers and amplifiers of inflammatory damage.
• Microglial activation — relevant to neuroinflammation and nervous-system inflammatory signaling.

This is why CBD is more than just a pain-relief trend. It has real anti-inflammatory mechanisms that are both highly specific and broad in the sense that it targets much more than just one pathway.

For example, in rheumatoid arthritis synovial fibroblast research, CBD has been shown to reduce inflammatory mediators including IL-6, IL-8, and MMP-3, especially under inflammatory TNF-activated conditions. That does not prove CBD treats rheumatoid arthritis in the clinic, but it does show a very relevant anti-inflammatory action in the exact tissue type involved in inflammatory joint disease.

So the way I think about CBD here is that CBD is not a universal anti-inflammatory — but rather an inflammation-modulating compound with stronger relevance to some inflammatory pathways than others. I almost always prefer to combine it with another herb with more specific affinity for a given condition.

The types of inflammation CBD seems most relevant for are inflammatory states involving cytokine signaling, oxidative stress, neurogenic inflammation, glial activation, irritated peripheral tissues, and inflammatory pain signaling.

This may help explain why CBD looks especially interesting for certain kinds of joint discomfort, irritated tissues, inflammatory pain states, skin irritation, and nervous-system inflammation models.

Where the evidence gets weaker is with major disease-outcome claims.

In Crohn’s disease, for example, CBD-rich cannabis has improved symptoms and quality of life in some research, but without clearly improving inflammatory markers or endoscopic inflammation. That’s an important distinction to point out because someone may feel better without the underlying inflammatory disease process being corrected.

Another important caveat I need to make here is that the form of CBD you’re using matters a lot. Most of the research on CBD’s anti-inflammatory properties uses high doses, consistent exposure, and longer treatment durations. You can’t just pop a CBD gummy in the morning and expect your inflammation to clear up.

For muscle and joint-type patterns, I typically think about it from both ends — a high-potency cream directly over the area, combined with a high-potency oil or capsule to support the same process systemically.

Nausea & Vomiting

CBD is often overlooked in nausea discussions because THC has the stronger medical history here. Which makes sense… THC-like medicines have long been used for chemotherapy-induced nausea and vomiting, and the cannabinoid system is clearly involved in nausea control.

But CBD has some real support here as well. Preclinical research suggests CBD can reduce nausea-like behavior and vomiting, with a likely role for 5-HT1A signaling. CBDA, the raw acidic form of CBD, may be even more potent in some anti-nausea models.

Nausea is controlled by several overlapping systems — the gut, vagus nerve, brainstem, vestibular system, serotonin signaling, dopamine signaling, endocannabinoid tone, inflammation, stress, memory, and conditioned responses.

This is why nausea from chemotherapy, motion sickness, anxiety, gastroparesis, migraine, pregnancy, infection, medication side effects, and cannabis hyperemesis aren’t all the same problem.

CBD appears to be most relevant where nausea overlaps with:

• stress or anticipatory nausea
• gut hypersensitivity
• inflammatory gut irritation
• functional nausea
• gastroparesis-like symptoms
• nervous-system sensitization
• THC-induced anxiety or overstimulation
• conditioned nausea responses

There is also some emerging human evidence. For example, a randomized placebo-controlled trial in idiopathic and diabetic gastroparesis found that pharmaceutical-grade CBD improved overall gastroparesis symptom scores and reduced symptoms, including inability to finish a normal meal and vomiting episodes, though, interestingly, it also slowed gastric emptying.

CBD may help nausea in some contexts while being the wrong fit in others. If nausea is caused by delayed gastric emptying, reflux, obstruction, infection, pregnancy complications, medication toxicity, or an unexplained serious illness, it should not be treated casually.

This is exactly where a full-spectrum CBD oil earns its keep. A lot of the strongest antiemetic signal comes from whole-plant preparations that keep a little THC alongside the CBD — a 2024 trial found THC an effective add-on for chemotherapy nausea even after standard anti-sickness drugs had been given (at the cost of more side effects). A good full-spectrum oil carries that same trace THC, plus CBDA and the plant’s other antiemetic compounds, which is why a whole-plant oil tends to outperform a stripped-down CBD isolate for nausea. Here, it really is the oil you want, not the isolate.

So my position is that a good full-spectrum CBD oil is genuinely useful across a range of nausea patterns — particularly those involving stress signaling, gut sensitivity, inflammatory irritation, conditioned nausea, or nervous-system dysregulation.

Where it should not be used is nausea or vomiting associated with persistent, unexplained, pregnancy-related, or medication-related illness, or anything associated with dehydration, abdominal pain, blood, fever, or repeated vomiting.

Psychotic Symptoms (Add-On Support)

CBD has been studied as an add-on to standard antipsychotic medication — not a replacement for it — mostly in schizophrenia.

This is one of the more surprising directions in cannabinoid research, because cannabis has the opposite reputation: high-THC cannabis is linked to triggering and worsening psychosis. CBD behaves very differently from THC here, and that contrast is the whole story.

The studies are genuinely interesting. In a 2018 randomized controlled trial, adding high-dose CBD (around 1,000 mg/day) on top of patients’ existing antipsychotics improved their symptoms, with clinicians rating them as more improved than the placebo group. An earlier trial ran CBD head-to-head against a standard antipsychotic (amisulpride) and found comparable improvement — but with far fewer side effects, and the benefit tracked with rising levels of the body’s own endocannabinoid, anandamide.

That points to the mechanism researchers care about most. Standard antipsychotics work mainly by blocking dopamine, which drives a lot of their side effects — weight gain, movement problems, heavy sedation. CBD doesn’t block dopamine the same way; it seems to act through the endocannabinoid system (partly by raising anandamide) and other pathways, which may be why it’s so well tolerated. The focus right now is squarely on CBD as an add-on that could improve symptoms without piling on side effects — not as a standalone antipsychotic.

There’s a product caveat here that’s unique to this use. Because THC can worsen psychotic symptoms in vulnerable people, this is the one application where you specifically do not want a full-spectrum oil. If CBD is used at all, it should be a THC-free product — a CBD isolate, or a properly lab-verified broad-spectrum extract.

And the usual caution applies more here than anywhere else in this guide. Psychosis is serious, the trial doses are many times ordinary consumer CBD, and this is not a “try a gummy and see” situation. It should always be clinician-supervised, and never self-treated.

Substance-Use Cravings

CBD has been studied for addictive behaviors and substance-use cravings.

The most interesting signal appears around cue-induced craving — the kind of craving triggered by environmental cues, stress, memory, or exposure to reminders of the substance.

This makes pharmacological sense. CBD may influence anxiety, stress reactivity, sleep, reward pathways, and conditioned fear responses. All of these can play a role in relapse vulnerability.

But the evidence is still pretty early here.

CBD should not be framed as a cure for addiction — it is not. Addiction is complex. It involves biology, trauma, environment, social support, habit loops, access, nervous system regulation, and more. There is no one substance that can cure the addiction complex — a successful recovery plan usually involves a much more multimodal approach.

My honest position here is that CBD may become a useful supportive tool for some substance-use patterns when used alongside other modalities like talk therapy, peer support, nervous-system regulation, and psychedelic-assisted therapy where legally available and clinically appropriate.

It is not the treatment. It may be one supportive lever inside a much larger treatment process.

Sleep

I constantly see CBD positioned as a natural sleep cure. Like some kind of miracle sedative.

This is one of those claims that’s actually true — CBD genuinely helps a lot of people sleep — just usually for a different reason than the marketing implies.

Let me explain.

CBD does not behave like a classic sedative. It does not simply knock people out. In some people, especially at lower doses, it may even have a mild stimulating action. I’ve felt this myself — I sometimes feel like CBD has a mild nootropic quality, especially in smaller doses. This is obviously not conducive to falling asleep quickly.

When CBD does help sleep, it may be because it reduces something else that was interfering with sleep — anxiety, stress reactivity, pain, restlessness, or nighttime rumination.

And that’s not a small thing. Pain, anxiety, a racing mind, physical restlessness — those are exactly what keep most people awake. Because CBD is genuinely good at easing them, it ends up being a powerful sleep aid for a lot of people — just through the back door, rather than by knocking you out. On top of that, a full-spectrum CBD oil that keeps a little THC (and often some CBN) is more directly sedating than CBD on its own, which is where CBD oil really tends to shine for sleep.

That distinction matters a lot.

If someone sleeps poorly because they’re anxious, CBD could genuinely help. If they sleep poorly because they consumed caffeine too late in the day, have sleep apnea, were out drinking, have poor light exposure, or spend too much time on screens at night — CBD is very unlikely to touch the real problem.

Product formulation matters a lot here too. There are a lot of seriously underpowered CBD products marketed for sleep that just don’t have the dose to justify the claim. CBD is not usually a “one tiny gummy and you’re out” kind of herb. For many people, the real effects show up only at more meaningful doses — and taking too little may feel subtle, neutral, or even mildly alerting.

I also see a lot of “CBD sleep” products that contain other ingredients like melatonin, CBN, L-theanine, passionflower, chamomile, lemon balm, or magnesium. These formulas can be great if they work — but just know that CBD isn’t the only reason.

If your goal is to evaluate a CBD sleep product, I’d look for a formula with a clearly listed CBD dose per serving, a current certificate of analysis, and supporting ingredients that actually make sense for sleep. Avoid the scammy low-dose products altogether. If there’s no mg listed on the bottle, find another product that does list it.

Usually, no dose = low dose.

Pain

Pain is one of the biggest CBD claims online — and while the marketing overstates parts of it, the underlying reality is genuinely strong: the right CBD oil can be excellent for pain.

The cannabis plant actually has a long history of use for pain, and cannabinoid-based medicines have been shown to help certain pain states. But much of the stronger clinical evidence involves THC-containing products or balanced THC:CBD extracts, not CBD alone.

This matters because THC and CBD do different things.

THC directly activates cannabinoid receptors involved in pain signaling. CBD works more indirectly and may influence inflammation, TRP channels, endocannabinoid tone, and nervous-system sensitivity. That may still count for something, but it’s not the same pharmacology.

Topical CBD is useful for localized discomfort, especially in formulas that include other well-chosen ingredients. But again, the word “CBD” on a cream does not prove the formula is effective.

This is why the product matters so much for pain. A high-dose, full-spectrum CBD oil that keeps some THC and the plant’s other cannabinoids can work wonders — this is usually what people mean when they say CBD “fixed” their pain. The honest caveat is that it doesn’t help every kind of pain or every person: some get dramatic relief, others feel very little. But matched to the right pain, a proper full-spectrum oil is one of the better natural options there is.

Why it helps some people and not others isn’t fully clear — but there are clues. CBD only dampens certain inflammatory pathways (the same selectivity described in the inflammation section), and pain has many different drivers — so it tends to land best on pain that runs through the inflammatory and nervous-system routes CBD actually touches, and to miss the pain that doesn’t. Dose is the other half of it: the amounts that do anything meaningful for pain are generally high, and a lot of people who “tried CBD and it did nothing” were simply underdosing.

Just go in knowing it won’t touch every kind of pain — but when it fits, it fits well.

Neuroprotection

CBD is often discussed for neuroprotection, Alzheimer’s disease, Parkinson’s disease, traumatic brain injury, and brain aging.

While there are definitely some interesting studies we could examine here, most of it is preclinical and based on animal or in vitro models. There just isn’t enough evidence to support the idea that CBD can prevent neurodegeneration or reverse brain aging.

CBD may affect oxidative stress, inflammation, excitotoxicity, mitochondrial function, glial activation, and endocannabinoid signaling — each of which are relevant to neurodegenerative disease.

But this is not enough to claim CBD prevents or treats neurodegeneration.

Brain diseases are complex, long-developing, and difficult to modify. Lab models rarely translate cleanly into human outcomes.

I’m not saying CBD can’t support people with these conditions, but based on the evidence available today, there are better, more targeted herbs to look at for these types of conditions.

CBD may still have a role where neuroinflammation, anxiety, sleep disruption, or inflammatory pain are part of the picture. But as a direct “brain-protective” supplement, the claim is still ahead of the evidence.

Skin & Topical Use

Topical CBD is a strange category.

On paper, it makes a lot of sense. The skin has its own endocannabinoid signaling, and since we know CBD can influence inflammation, irritation, sebum production, pain signaling, and local immune tone — it should offer real local benefits.

But in practice, a lot of topical CBD products are too weak to do much of anything. CBD is used more as a marketing tool in this category than as a serious therapeutic ingredient. It’s hard to find CBD topicals with meaningful amounts of CBD in them — and the ones that are available are usually very expensive.

A good topical product needs more than CBD. It needs the right base, the right concentration, the right delivery system, and supporting ingredients that match the goal.

Just a few examples of what I mean here:

• A muscle/joint formula may need counterirritants, warming herbs, cooling herbs, magnesium, menthol, or anti-inflammatory botanicals.
• A skin-barrier formula needs ceramides, oils, humectants, or synergistic soothing herbs.
• An acne-focused formula would need to address sebum, inflammation, microbiome balance, and irritation.

CBD may contribute to the formula — but it should not be the whole formula.

This is why I’d judge CBD topicals less by the word “CBD” on the label and more by the formula architecture. How much CBD is actually in it? Is the base designed to deliver it? Are there other herbs or compounds supporting the same goal? Is it built for pain, skin barrier repair, acne, itching, or inflammation?

A good CBD topical can make sense. Most CBD topicals are just expensive cream with a trendy ingredient sprinkled in.

Cancer

CBD and other cannabinoids have shown interesting effects in cancer cell lines and animal models.

Unfortunately, this is not the same thing as treating cancer in humans.

A good analogy here is that if you culture cancer cells in a petri dish and then blast them with something harsh enough, the cancer cells will certainly die. But we absolutely cannot extrapolate this to “this cures cancer.”

Crude metaphor, I know, but this is legitimately what happens in a lot of early cancer research. Cancer cells are cultured, exposed to high concentrations of CBD or other cannabinoids, and then, when some of those cells die, it gets reported as though CBD is a new cancer treatment.

More often than not, when these findings are translated into actual human models, the results are underwhelming. Not useless, necessarily — just nowhere near as clean or dramatic as the early cell studies made them look. CBD studies have not been much different.

I find that this is one of the most dangerous areas of CBD marketing because the language can slide from “interesting preclinical research” into “natural cancer cure” very quickly. And so far, it’s just not supported.

CBD should never be used as a replacement for oncology care.

It may have a role in supportive care for some people — for example, helping with anxiety, sleep, appetite, discomfort, chemotherapy-related nausea, or general quality-of-life support — but even that depends on the person, the product, the medication list, and the cancer treatment plan.

Cancer treatment is not the place for supplement guesswork.

I should also point out that, much like inflammation, “cancer” refers to a very wide range of diseases. What works for one type of cancer may have no impact on another. Breast cancer, glioblastoma, leukemia, melanoma, colon cancer, prostate cancer, and pancreatic cancer are not the same disease with the same biology.

So the honest position is simple:

CBD is interesting in cancer research, but it is not a cancer treatment.

Anyone using CBD during cancer care should discuss it with their oncology team first, especially because CBD can interact with medications and may affect how some drugs are metabolized.

Glaucoma

Cannabis has a long association with glaucoma, but the claim is wildly misunderstood.

The old glaucoma discussion mostly centers on THC temporarily lowering intraocular pressure. Even there, the effect is short-lived and not very practical as a primary treatment. You would have to maintain the effect with repeated high-THC cannabis exposure every few hours — which is not a realistic or medically appropriate glaucoma strategy.

I say high-THC because studies suggest it’s actually the THC that drives this effect. CBD does not appear to lower intraocular pressure in the same way, and may even have the opposite effect — potentially making glaucoma worse.

This is a good example of why “cannabis helps X” does not mean “CBD helps X.”

THC and CBD are different compounds with different pharmacology. For glaucoma, CBD is not just unproven — it may be the wrong tool entirely.

CBD Product Types: Isolate, Broad-Spectrum & Full-Spectrum

One of the biggest questions I get asked about CBD products in general is whether someone should use CBD isolate, full-spectrum extracts, or broad-spectrum extracts.

Let’s address this head on because the answer is, unfortunately, it depends.

CBD Isolate

CBD isolate is essentially pure cannabidiol.

It’s clean, predictable, easy to standardize, and useful when THC has to be avoided completely. That matters for people who are drug-tested, people who are unusually sensitive to THC, and situations where even trace THC is unacceptable.

The downside is that isolate removes everything else provided by the plant. There are no minor cannabinoids, no terpenes, no acidic cannabinoids. The whole-resin complexity of the cannabis plant and its natural synergy is a big part of its usefulness. Removing these compounds not only limits its range, but likely reduces the effectiveness of the CBD itself.

That doesn’t make isolate useless. It just makes it narrower.

CBD isolate is best for:

• People who need verified THC-free products
• Drug-testing situations
• People sensitive to THC
• High-dose CBD protocols where standardization matters
• Research or clinical contexts where isolated CBD is preferred

Weaknesses:

• Lacks the broader plant chemistry
• May require higher doses for some effects
• Less aligned with traditional whole-plant herbalism

Full-Spectrum CBD

Full-spectrum CBD is the form I usually prefer from a herbalist’s perspective.

Cannabis is a chemically rich plant, and the supporting cannabinoids, terpenes, and other resin compounds may contribute to the overall effect. This is the basic idea behind the entourage effect.

The entourage effect is not a free pass for marketing claims. It’s a useful concept, but not every full-spectrum product is automatically better.

A good full-spectrum oil should come with a batch-matched certificate of analysis showing:

• CBD content
• THC content
• minor cannabinoids
• terpene profile, ideally
• contaminants
• residual solvents
• batch number
• test date

The main reason to avoid full-spectrum CBD isn’t because the trace THC is likely to feel psychoactive at ordinary product exposures. The bigger issue is constraint.

Full-spectrum may not be appropriate for:

• pregnancy or breastfeeding
• minors
• workplace drug testing
• THC sensitivity
• legal restrictions
• people who need a hard zero on THC
• people who personally prefer to avoid THC entirely

In those cases, use isolate or broad-spectrum instead.

Broad-Spectrum CBD

Broad-spectrum CBD is the middle ground between isolates and full-spectrum products.

It contains CBD plus other cannabis compounds, but the THC has been removed or reduced to non-detectable levels.

This can be useful when someone wants more of the plant’s supporting chemistry but still wants to avoid THC.

The problem is that “broad-spectrum” is only meaningful if the lab report proves it.

Some products use the term loosely — such as mixing CBD isolate with CBC or CBN isolate, or adding a few terpene extracts to the final product. These types of broad-spectrum products have removed so much of the plant chemistry they’re functionally closer to isolate than not.

Broad-spectrum is best for:

• People who want non-THC cannabis chemistry
• People avoiding THC but wanting more than isolate
• Daytime products where intoxication is not acceptable

Weaknesses:

• Quality varies widely
• Some are basically isolates with marketing
• “THC-free” should always be verified by a COA

How Much THC Is In Full-Spectrum CBD?

This is where labels get confusing.

Hemp-derived CBD products are often described as containing “less than 0.3% THC.” But that legal threshold refers to hemp by dry weight. It does not automatically tell you how much THC is in your dose.

The number that matters is the certificate of analysis.

A good COA should tell you how much THC is present in one of these formats:

• mg per mL
• mg per serving
• mg per gram
• percent by weight

That number matters for two reasons.

First, trace THC can accumulate across multiple servings. Second, some people need to avoid THC entirely, even if the amount is too low to feel intoxicating.

For most adults using ordinary full-spectrum CBD products as directed, the trace THC is unlikely to produce a classic cannabis high. But “unlikely to feel psychoactive” is not the same as “zero.”

Drug testing is a separate issue.

A product can feel non-intoxicating and still contain enough THC exposure to create concern for someone who is tested at work.

So the practical rule is:

If THC must be zero, do not rely on full-spectrum CBD. Use verified THC-free isolate or broad-spectrum CBD with a current COA.

How To Use CBD Therapeutically

CBD products come in several forms. None are perfect. The best choice depends on the person, the goal, the needed precision, and the quality of the product.

For health-focused use, I generally prefer products that are measurable, lab-tested, and easy to dose consistently.

That usually means oils, capsules, or well-made tinctures.

1. CBD Oils

CBD oils are extracts dissolved into a carrier oil like MCT oil, olive oil, or hempseed oil.

They’re popular because they’re flexible. You can adjust the amount, use them under the tongue, swallow them, or add them to food.

Oils are also easy to compare if you know the label math.

The key number is mg of CBD per mL.

For example: 1000 mg CBD in a 30 mL bottle = 33.3 mg CBD per mL.

That tells you the strength of the product much better than the front label does.

For all of these reasons, CBD oils are generally the form I prefer to use.

2. CBD Capsules

CBD capsules are simple — each capsule contains a fixed amount of CBD.

This makes them easier for people who hate measuring drops or doing calculations. They’re also convenient for travel and routine use.

The trade-off is flexibility.

You can’t easily fine-tune a capsule dose. You also can’t hold it under the tongue, so onset is usually slower than sublingual oils.

3. CBD Edibles

CBD gummies and edibles are popular because they’re easy and usually taste pretty good.

They’re also one of the categories most prone to weak formulas, sugar-heavy products, inflated claims, and sloppy dosing. It’s rare to find high-quality full-spectrum gummies, because cannabis resin usually causes the gummy to lose its gelatin texture. Most gummies use isolate instead for this reason.

The main benefit of using gummies is convenience. The downside is that edibles are slower, less adjustable, and often more expensive per mg of CBD.

They can also make people forget they’re taking an active compound. It’s easy to take way too many gummies because they’re delicious.

4. Topical CBD

Topical CBD products include creams, salves, balms, lotions, and gels.

They’re used for localized issues — muscle tension, joint discomfort, skin irritation, and sometimes acne or inflammatory skin conditions.

The problem is that many topical CBD products are poorly designed.

A good topical formula should not rely on CBD alone. It should include supporting ingredients that match the purpose of the product.

For muscle and joint formulas, that might include cooling, warming, circulatory, or anti-inflammatory botanicals. For skin formulas, it might include barrier-supportive oils, humectants, soothing herbs, or anti-irritant compounds.

5. Raw Flower, Smoking & Vaping

Raw cannabis flower contains the plant’s resin directly. It can be smoked, vaporized, or processed into extracts.

From a traditional herbal perspective, whole flower has value because it is the least processed form of the plant.

From a health perspective, smoking is obviously a problem.

Inhaling combusted plant material is not a clean delivery method. If the goal is health promotion, smoking should generally be avoided.

Vaping avoids combustion, but it introduces its own concerns — additives, thinning agents, heating byproducts, device quality, and lung exposure.

There are other forms of vapes that use the raw herb directly. They heat the plant material up so the cannabinoids and terpenes can be inhaled, but without actually combusting the plant material. These forms of vapes are preferred.

For most health-focused CBD use, oils, capsules, tinctures, and well-designed topicals are easier to evaluate and safer to standardize.

How To Think About CBD Dose

CBD dosing is not as clean as people want it to be.

Different studies use different doses. Different products absorb differently. People vary in bodyweight, metabolism, sensitivity, medications, liver function, endocannabinoid tone, and what they’re using CBD for.

The most important principle is not “take this exact amount” — it’s more about knowing how much CBD is in the product, how much is in each serving, and avoiding pretending the dose is precise if the label math is unclear.

For adult consumers, CBD products are often discussed in broad exposure ranges:

Exposure range	Approx. CBD amount	Notes
Low	5–20 mg/day	Common in wellness products; may be subtle.
Moderate	25–75 mg/day	Common consumer range for stress, sleep, or general use.
High	100 mg+/day	More likely to involve side effects, interactions, and cost. Best approached with professional guidance.
Clinical high-dose	mg/kg dosing	Used in some medical research and prescription CBD contexts; not comparable to casual OTC use.

These are not instructions — they’re orientation points. Everybody is different here, so standardizing the dose is almost impossible.

The Label Math That Actually Matters

Before thinking about dose, calculate the product strength.

CBD per mL

Use this formula:

Total CBD in bottle ÷ bottle size in mL = CBD per mL

Example: 1000 mg CBD ÷ 30 mL = 33.3 mg/mL

CBD per drop

A common estimate is 20 drops per mL, but droppers vary.

Using the example above: 33.3 mg/mL ÷ 20 drops = about 1.7 mg CBD per drop

This is why stronger oils are not automatically better or worse. They’re just more concentrated.

A weak oil may require a large volume to reach the same CBD amount. A strong oil may require only a few drops.

The math matters more than the marketing.

How To Avoid Junk CBD

There is a lot of bad CBD on the market.

Some products contain less CBD than advertised. Some contain more THC than expected. Some contain pesticides, heavy metals, residual solvents, microbial contamination, or rancid carrier oils. Some are simply too weak to do anything meaningful.

This is the dark side of the CBD industry.

When a compound becomes trendy, companies race to put it in everything. The result is predictable: weak gummies, overpriced oils, vague “hemp extract” labels, fake full-spectrum claims, and brands that hide behind marketing instead of lab reports.

Trust me on this. I’ve worked with numerous hemp companies over the years, and it’s shocking to see the level of sloppiness a lot of these companies operate with.

My advice here is simple: don’t trust the front of the bottle. Trust the certificate of analysis.

1. Demand A Current Certificate Of Analysis

A certificate of analysis, or COA, is a lab report showing what’s actually in the product.

A good COA should be:

• current
• batch-matched
• from an independent lab
• ideally from an ISO-accredited lab
• specific to the product being sold
• complete enough to include potency and contaminants

Check that the COA shows:

• CBD content
• THC content
• minor cannabinoids
• heavy metals
• pesticides
• residual solvents
• microbial contaminants
• mycotoxins, ideally
• test date
• batch or lot number

If the company does not publish a COA, skip the product. If the COA is old, skip the product. If the COA does not match the batch number, skip the product. If the COA only shows CBD and nothing else, be cautious — potency is only part of quality.

2. Check Whether The Label Matches The Lab

A CBD label can say anything.

The COA is where the claim gets tested.

Look for mismatches like:

• Label says 1000 mg CBD, lab shows much less
• Label says THC-free, lab shows detectable THC
• Label says full-spectrum, lab shows CBD isolate only
• Label says broad-spectrum, lab shows no minor cannabinoids
• Label says hemp extract but does not list CBD clearly
• Product has no batch number
• Product has no contaminant testing

The biggest red flag is vagueness.

A serious CBD company should be able to tell you exactly what’s in the bottle.

3. Look At The Cannabinoid Profile

The cannabinoid profile tells you what kind of extract you’re dealing with.

A full-spectrum CBD oil should show more than CBD. You may see small amounts of:

• THC
• THCA
• CBDV
• CBDA
• CBG
• CBGA
• CBC
• CBN
• other minor cannabinoids

A broad-spectrum product should show CBD and some supporting cannabinoids, but no detectable THC.

An isolate product should show CBD and little else.

None of these are automatically good or bad. The point is that the lab report should match the product claim.

4. Watch The Carrier Oil

CBD oil is not just CBD.

It’s CBD extract dissolved in a carrier oil.

Common carrier oils include:

• MCT oil
• olive oil
• hempseed oil
• sunflower oil
• avocado oil

The carrier oil affects taste, stability, texture, and tolerability.

Avoid products with:

• rancid-smelling oils
• vague “proprietary oil blends”
• unnecessary artificial flavors
• sketchy preservatives
• ingredients you wouldn’t normally ingest

This matters even more for people with allergies or sensitive digestion.

5. Be Skeptical Of CBD Vapes

CBD vapes should be treated cautiously.

The issue is not just CBD. It’s the delivery system: solvents, thinning agents, flavorings, heating byproducts, cartridge quality, and lung exposure.

For a health-focused herbal approach, vaping CBD is rarely the first choice.

A CBD oil with a clean COA is easier to evaluate than a flavored vape cartridge.

6. Don’t Overpay For Weak Products

Some CBD products are expensive because they’re high quality.

Others are expensive because the label is pretty.

The easiest way to compare value is to calculate price per mg of CBD:

Product price ÷ total CBD = price per mg CBD

Example: $60 ÷ 1000 mg CBD = $0.06 per mg CBD

This does not tell you everything. A well-made full-spectrum oil may cost more than a cheap isolate. But price-per-mg helps you spot absurd markups.

A $50 jar of gummies with 5 mg CBD each may be more candy than medicine.

Safety & Drug Interactions

CBD is generally well tolerated, but it is not pharmacologically neutral.

The biggest safety issue is drug interaction.

CBD can affect liver enzymes involved in drug metabolism, especially CYP3A4 and CYP2C19, with possible effects on CYP2C9 and other pathways. That means CBD can change how quickly some medications are broken down.

The FDA-approved CBD drug Epidiolex carries warnings around liver enzyme elevations, sedation, drug interactions, and interactions with anti-seizure medications such as clobazam and valproate. It also requires liver-related bloodwork before treatment.

Basically, if a medication has a grapefruit warning, CBD deserves caution too (it inhibits the same enzymes).

Medications That Deserve Extra Caution

People should be especially careful with CBD if they take:

• anti-seizure medications
• blood thinners such as warfarin
• sedatives
• sleep medications
• benzodiazepines
• alcohol
• antidepressants
• antipsychotics
• heart medications
• immunosuppressants
• transplant medications
• medications with a narrow therapeutic window
• multiple prescription medications

This does not mean CBD is automatically forbidden with all of these.

It means the risk-benefit calculation should involve a pharmacist, physician, or qualified clinician.

Common CBD Side Effects

Commonly reported CBD side effects include:

• sleepiness
• fatigue
• diarrhea
• appetite changes
• digestive upset
• dry mouth
• changes in alertness
• possible liver enzyme elevations at high exposures

Side effects are more likely when the dose is high, the person is sensitive, the product contains THC, or CBD is combined with medications or alcohol.

Pregnancy, Breastfeeding & Minors

CBD should be avoided during pregnancy and breastfeeding unless specifically directed by a qualified clinician.

This is not because we know CBD always causes harm. It’s because the safety data is not strong enough, and the developing fetus or infant is not the place to experiment with cannabinoid products.

The same caution applies to minors.

CBD and cannabis products should not be used by children or teenagers without medical supervision. The major exception is prescription CBD for specific seizure disorders, where use is clinician-directed, dose-controlled, and monitored.

CBD Bottom Line

CBD is useful, but it’s not magic.

As a herbal medicine, CBD is genuinely interesting — non-intoxicating, pharmacologically active, endocannabinoid-relevant, and supported by strong evidence in at least one medical context.

As a wellness product, it’s wildly overmarketed.

Outside of approved seizure-disorder treatment, CBD is best understood as promising for a few areas, especially anxiety, and still early or shaky for many of the claims attached to it.

The smartest way to use CBD is not to chase the trend.

It’s to ask better questions:

• What is the evidence for this specific use?
• Is this CBD alone, or a THC:CBD product?
• Is it isolate, broad-spectrum, or full-spectrum?
• What does the COA show?
• How much CBD is actually in each serving?
• How much THC is present?
• Is this person on medications?
• Is there a reason THC must be zero?
• Is this the right tool, or just the trendiest one?

CBD deserves neither blind hype nor lazy dismissal.

It deserves the same thing every herbal medicine deserves: good sourcing, realistic expectations, careful dosing, and respect for its pharmacology.

Author

Justin Cooke, BHSc

The Sunlight Experiment